Nanotechnology increasingly used in medical devices The application of nanotechnology to design and produce medical devices is increasing. RIVM provides an overview of nanotechnology enabled medical devices.
Greater influx of migrants not expected to lead to an increase in cases of tuberculosis According to the RIVM report ‘Tuberculosis in the Netherlands 2014’, a total of 823 people were diagnosed with TB last year. That is 21 fewer patients than in 2013.
Replacement possible for products with carcinogenic formaldehyde There seem to be sufficient alternatives available for the majority of disinfectants and preservatives containing the carcinogenic substance formaldehyde.
WHO’s first ever global estimates of foodborne diseases: children under five account for almost one third of deaths Almost one third (30%) of all deaths from foodborne diseases are in children under the age of five years, despite the fact that they make up only 9% of the global population.
Air quality improved, not everywhere below limit values In recent years there has been a decline in the average concentrations of fine particulates and nitrogen dioxide.
Measures EU cities against effects of climate change Some European cities have developed effective policies to adapt to more frequent wet and dry periods forecast for the years ahead, as a result of climate change.
Further research into hazards posed by e-cigarettes Safety of nicotine-containing electronic cigarettes (e-cigarettes) cannot be confirmed because of the limited amount of published research in this area.
Drinking water protection files are steadily progressing Local and provincial authorities, drinking water supply companies and water resource managers authority are making progress with the assessment of the current and future risks for the quality of ex
New bacterium in ticks Last year, a man was treated at the Amsterdam Academic Medical Centre (AMC) after being bitten by a tick and becoming infected with a strain of the Borrelia bacterium not previously encountered in
Regional differences in testing rates underestimate incidence of LGV epidemic Until 2003, Lymphogranuloma venereum (LGV), an aggressive form of chlamydia, was considered to be a rare tropical disease, endemic to Africa, Asia and the Caribbean.